Characteristics of common solid liver lesions and recommendations for diagnostic workup

World Journal of Gastroenterology

Volumn 15, Issue 26, 2009, Pages 3217-3227

  Assy, Nimer ^a,b   Nasser, Gattas ^a   Djibre, Agness ^c   Beniashvii, Zaza ^a   Elias, Saad ^a   Zidan, Jamal ^a,b  

^a Rebecca Sieff Government Hospital   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c WESTERN GALILEE HOSPITAL   (Israel)

Author keywords

Biopsy; Cirrhosis; Computed tomography; Fine needle aspiration; Hepatic nodule; Hepatocellular carcinoma; Lesion; Liver mass; Magnetic resonance imaging; Tumor; Ultrasonography

Indexed keywords

ALPHA FETOPROTEIN; GADOLINIUM; TUMOR MARKER;

ANGIOSARCOMA; ASPIRATION BIOPSY; BENIGN TUMOR; BILE DUCT CARCINOMA; BILE DUCT TUMOR; BILIARY PAPILLOMATOSIS; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; CYSTADENOCARCINOMA; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FATTY LIVER; FIBROLAMELLAR CARCINOMA; FIBROSARCOMA; HEMANGIOENDOTHELIOMA; HEPATOBILIARY CYST ADENOMA; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; INTERMETHOD COMPARISON; LEIOMYOSARCOMA; LIVER ADENOMA; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FOCAL NODULAR HYPERPLASIA; LIVER HEMANGIOMA; LIVER METASTASIS; LIVER NODULE; LIVER RESECTION; LIVER SARCOMA; LIVER TUMOR; MALIGNANT NEOPLASTIC DISEASE; MESENCHYMOMA; NEEDLE BIOPSY; NEUROENDOCRINE TUMOR; NEUROMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA CELL GRANULOMA; PRIMARY TUMOR; REVIEW; RHABDOMYOSARCOMA; SOLID TUMOR; TUMOR VOLUME;

EID: 67651183869     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.3217     Document Type: Review

References (131)

1. Giannitrapani L, Soresi M, La Spada E, Cervello M, D'Alessandro N, Montalto G. Sex hormones and risk of liver tumor. Ann N Y Acad Sci 2006; 1089: 228-236
2. Dogliotti E. Molecular mechanisms of carcinogenesis by vinyl chloride. Ann Ist Super Sanita 2006; 42: 163-169
3. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004; 24: 115-125
4. Borentain P, Gérolami R, Dodero F, Chrestian MA, Quillichini F, Ardissone J, Perrimond H, Chamlian A, Gérolami A. [High serum alkaline phosphatase level revealing a liver adenoma] Gastroenterol Clin Biol 2006; 30: 304-306
5. Coakley FV, Schwartz LH. Imaging of hepatocellular carcinoma: a practical approach. Semin Oncol 2001; 28: 460-473
6. Karhunen PJ, Penttilä A, Liesto K, Männikkö A, Möttönen MM. Occurrence of benign hepatocellular tumors in alcoholic men. Acta Pathol Microbiol Immunol Scand A 1986; 94: 141-147
7. Hussain SM, Semelka RC. Liver masses. Magn Reson Imaging Clin N Am 2005; 13: 255-275
8. Seitz G. [Why are metastases in cirrhotic livers so rare?] Ultraschall Med 1989; 10: 123-126
9. Hussain SM, Terkivatan T, Zondervan PE, Lanjouw E, de Rave S, Ijzermans JN, de Man RA. Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics 2004; 24: 3-17; discussion 18-19
10. Okuda K. Early recognition of hepatocellular carcinoma. Hepatology 1986; 6: 729-738
11. Sherman M. Alphafetoprotein: an obituary. J Hepatol 2001; 34: 603-605
12. Ramage JK, Donaghy A, Farrant JM, Iorns R, Williams R. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 1995; 108: 865-869
13. Caturelli E, Solmi L, Anti M, Fusilli S, Roselli P, Andriulli A, Fornari F, Del Vecchio Blanco C, de Sio I. Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study. Gut 2004; 53: 1356-1362
14. Tsao JI, DeSanctis J, Rossi RL, Oberfield RA. Hepatic malignancies. Surg Clin North Am 2000; 80: 603-632
15. Balci NC, Befeler AS, Leiva P, Pilgram TK, Havlioglu N. Imaging of liver disease: comparison between quadruple-phase multidetector computed tomography and magnetic resonance imaging. J Gastroenterol Hepatol 2008; 23: 1520-1527
16. Murakami T, Oi H, Hori M, Kim T, Takahashi S, Tomoda K, Narumi Y, Nakamura H. Helical CT during arterial portography and hepatic arteriography for detecting hypervascular hepatocellular carcinoma. AJR Am J Roentgenol 1997; 169: 131-135
17. Hori M, Murakami T, Kim T, Takahashi S, Oi H, Tomoda K, Narumi Y, Nakamura H. Sensitivity of double-phase helical CT during arterial portography for detection of hypervascular hepatocellular carcinoma. J Comput Assist Tomogr 1998; 22: 861-867
18. van Kouwen MC, Oyen WJ, Nagengast FM, Jansen JB, Drenth JP. FDG-PET scanning in the diagnosis of gastrointestinal cancers. Scand J Gastroenterol Suppl 2004; 85-92
19. Kinnard MF, Alavi A, Rubin RA, Lichtenstein GR. Nuclear imaging of solid hepatic masses. Semin Roentgenol 1995; 30: 375-395
20. Martínez-Lázaro R, Domínguez P, Pascau J, Bittini A, Lafuente J, Desco M. Usefulness of Tc-99m RBC SPECT/MRI fusion imaging in small suspected hepatic hemangiomas. Clin Nucl Med 2004; 29: 844-845
21. Kanematsu M, Hoshi H, Yamada T, Murakami T, Kim T, Kato M, Yokoyama R, Nakamura H. Small hepatic nodules in cirrhosis: ultrasonographic, CT, and MR imaging findings. Abdom Imaging 1999; 24: 47-55
22. Gandhi SN, Brown MA, Wong JG, Aguirre DA, Sirlin CB. MR contrast agents for liver imaging: what, when, how. Radiographics 2006; 26: 1621-1636
23. Solbiati L, Tonolini M, Cova L, Goldberg SN. The role of contrast-enhanced ultrasound in the detection of focal liver leasions. Eur Radiol 2001; 11 Suppl 3: E15-E26
24. Torzilli G, Makuuchi M, Ferrero A, Takayama T, Hui AM, Abe H, Inoue K, Nakahara K. Accuracy of the preoperative determination of tumor markers in the differentiation of liver mass lesions in surgical patients. Hepatogastroenterology 2002; 49: 740-745
25. França AV, Valério HM, Trevisan M, Escanhoela C, Sevá-Pereira T, Zucoloto S, Martinelli A, Soares EC. Fine needle aspiration biopsy for improving the diagnostic accuracy of cut needle biopsy of focal liver lesions. Acta Cytol 2003; 47: 332-336
26. Borzio M, Borzio F, Macchi R, Croce AM, Bruno S, Ferrari A, Servida E. The evaluation of fine-needle procedures for the diagnosis of focal liver lesions in cirrhosis. J Hepatol 1994; 20: 117-121
27. Buscarini L, Fornari F, Bolondi L, Colombo P, Livraghi T, Magnolfi F, Rapaccini GL, Salmi A. Ultrasound-guided fine-needle biopsy of focal liver lesions: techniques, diagnostic accuracy and complications. A retrospective study on 2091 biopsies. J Hepatol 1990; 11: 344-348
28. Chawla YK, Ramesh GN, Kaur U, Bambery P, Dilawari JB. Percutaneous liver biopsy: a safe outpatient procedure. J Gastroenterol Hepatol 1990; 5: 94-95
29. Fornari F, Civardi G, Cavanna L, Di Stasi M, Rossi S, Sbolli G, Buscarini L. Complications of ultrasonically guided fine-needle abdominal biopsy. Results of a multicenter Italian study and review of the literature. The Cooperative Italian Study Group. Scand J Gastroenterol 1989; 24: 949-955
30. Smith EH. Complications of percutaneous abdominal fine-needle biopsy. Review. Radiology 1991; 178: 253-258
31. Edoute Y, Malberger E, Tibon-Fishe O, Assy N. Non-imaging-guided fine-needle aspiration of liver lesions: a retrospective study of 279 patients. World J Gastroenterol 1999; 5: 98-102
32. Cohen MB, Haber MM, Holly EA, Ahn DK, Bottles K, Stoloff AC. Cytologic criteria to distinguish hepatocellular carcinoma from nonneoplastic liver. Am J Clin Pathol 1991; 95: 125-130
33. Durand F, Regimbeau JM, Belghiti J, Sauvanet A, Vilgrain V, Terris B, Moutardier V, Farges O, Valla D. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol 2001; 35: 254-258
34. Ryder SD. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 2003; 52 Suppl 3: iii1-iii8
35. Caturelli E, Biasini E, Bartolucci F, Facciorusso D, Decembrino F, Attino V, Bisceglia M. Diagnosis of hepatocellular carcinoma complicating liver cirrhosis: utility of repeat ultrasound-guided biopsy after unsuccessful first sampling. Cardiovasc Intervent Radiol 2002; 25: 295-299
36. Torzilli G, Minagawa M, Takayama T, Inoue K, Hui AM, Kubota K, Ohtomo K, Makuuchi M. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology 1999; 30: 889-893
37. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodés J. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-430
38. Rapaccini GL, Pompili M, Caturelli E, Anti M, Aliotta A, Cedrone A, Amadei E, Grattagliano A, Squillante MM, Rabitti C. Focal ultrasound lesions in liver cirrhosis diagnosed as regenerating nodules by fine-needle biopsy. Follow-up of 12 cases. Dig Dis Sci 1990; 35: 422-427
39. Cedrone A, Covino M, Caturelli E, Pompili M, Lorenzelli G, Villani MR, Valle D, Sperandeo M, Rapaccini GL, Gasbarrini G. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients. Hepatogastroenterology 2000; 47: 1654-1658
40. Sherman M. Screening for hepatocellular carcinoma. Hepatol Res 2007; 37 Suppl 2: S152-S165
41. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745-750
42. Barbara L, Benzi G, Gaiani S, Fusconi F, Zironi G, Siringo S, Rigamonti A, Barbara C, Grigioni W, Mazziotti A. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 1992; 16: 132-137
43. Simonetti RG, Cammà C, Fiorello F, Politi F, D'Amico G, Pagliaro L. Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci 1991; 36: 962-972
44. Souto E, Gores GJ. When should a liver mass suspected of being a hepatocellular carcinoma be biopsied? Liver Transpl 2000; 6: 73-75
45. Mor E, Kaspa RT, Sheiner P, Schwartz M. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med 1998; 129: 643-653
46. Reddy KR, Schiff ER. Approach to a liver mass. Semin Liver Dis 1993; 13: 423-435
47. Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G, Piscaglia F, Gramantieri L, Zanetti M, Sherman M. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 2001; 48: 251-259
48. Peng YC, Chan CS, Chen GH. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma. Hepatogastroenterology 1999; 46: 3208-3211
49. Nakashima T, Kojiro M. Pathologic characteristics of hepatocellular carcinoma. Semin Liver Dis 1986; 6: 259-266
50. Terminology of nodular hepatocellular lesions. International Working Party. Hepatology 1995; 22: 983-993
51. Hussain SM, Zondervan PE, IJzermans JN, Schalm SW, de Man RA, Krestin GP. Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. Radiographics 2002; 22: 1023-1036; discussion 1037-1039
52. Craig JR. Fibrolamellar carcinoma: Clinical and pathologic features. In: Okuda K, Tabor E, eds. Liver Cancer. New York: Churchill Livingstone, 1997: 255-262
53. Melato M, Laurino L, Mucli E, Valente M, Okuda K. Relationship between cirrhosis, liver cancer, and hepatic metastases. An autopsy study. Cancer 1989; 64: 455-459
54. Johnson PJ. Role of alpha-fetoprotein in the diagnosis and management of hepatocellular carcinoma. J Gastroenterol Hepatol 1999; 14 Suppl: S32-S36
55. Wilson SR. Imaging of benign hepatic lesions. In: Freeny PC, ed. Radiology of the liver, biliary tree and pancreas. Reston: American Roentgen Ray Society, 1996: 17-25
56. Takagi H. Diagnosis and management of cavernous hemangioma of the liver. Semin Surg Oncol 1985; 1: 12-22
57. Cherqui D, Rahmouni A, Charlotte F, Boulahdour H, Métreau JM, Meignan M, Fagniez PL, Zafrani ES, Mathieu D, Dhumeaux D. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology 1995; 22: 1674-1681
58. Trastek VF, van Heerden JA, Sheedy PF 2nd, Adson MA. Cavernous hemangiomas of the liver: resect or observe? Am J Surg 1983; 145: 49-53
59. Stark DD, Felder RC, Wittenberg J, Saini S, Butch RJ, White ME, Edelman RR, Mueller PR, Simeone JF, Cohen AM. Magnetic resonance imaging of cavernous hemangioma of the liver: tissue-specific characterization. AJR Am J Roentgenol 1985; 145: 213-222
60. Sigal R, Lanir A, Atlan H, Naschitz JE, Simon JS, Enat R, Front D, Israel O, Chisin R, Krausz Y. Nuclear magnetic resonance imaging of liver hemangiomas. J Nucl Med 1985; 26: 1117-1122
61. Sewell JH, Weiss K. Spontaneous rupture of hemangioma of the liver. A review of the literature and presentation of illustrative case. Arch Surg 1961; 83: 729-733
62. Yamamoto M, Ariizumi S, Yoshitoshi K, Saito A, Nakano M, Takasaki K. Hepatocellular carcinoma with a central scar and a scalloped tumor margin resembling focal nodular hyperplasia in macroscopic appearance. J Surg Oncol 2006; 94: 587-591
63. Lizardi-Cervera J, Cuéllar-Gamboa L, Motola-Kuba D. Focal nodular hyperplasia and hepatic adenoma: a review. Ann Hepatol 2006; 5: 206-211
64. Rogers JV, Mack LA, Freeny PC, Johnson ML, Sones PJ. Hepatic focal nodular hyperplasia: angiography, CT, sonography, and scintigraphy. AJR Am J Roentgenol 1981; 137: 983-990
65. Rabe T, Feldmann K, Grunwald K, Runnebaum B. Liver tumours in women on oral contraceptives. Lancet 1994; 344: 1568-1569
66. Labrune P, Trioche P, Duvaltier I, Chevalier P, Odièvre M. Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr 1997; 24: 276-279
67. Grazioli L, Federle MP, Brancatelli G, Ichikawa T, Olivetti L, Blachar A. Hepatic adenomas: imaging and pathologic findings. Radiographics 2001; 21: 877-892; discussion 892-894
68. Erdogan D, Busch OR, van Delden OM, Ten Kate FJ, Gouma DJ, van Gulik TM. Management of spontaneous haemorrhage and rupture of hepatocellular adenomas. A single centre experience. Liver Int 2006; 26: 433-438
69. Mathieu D, Bruneton JN, Drouillard J, Pointreau CC, Vasile N. Hepatic adenomas and focal nodular hyperplasia: dynamic CT study. Radiology 1986; 160: 53-58
70. Kume N, Suga K, Nishigauchi K, Shimizu K, Matsunaga N. Characterization of hepatic adenoma with atypical appearance on CT and MRI by radionuclide imaging. Clin Nucl Med 1997; 22: 825-831
71. Colli A, Fraquelli M, Massironi S, Colucci A, Paggi S, Conte D. Elective surgery for benign liver tumours. Cochrane Database Syst Rev 2007; CD005164
72. Kerlin P, Davis GL, McGill DB, Weiland LH, Adson MA, Sheedy PF 2nd. Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features. Gastroenterology 1983; 84: 994-1002
73. Demarco MP, Shen P, Bradley RF, Levine EA. Intraperitoneal hemorrhage in a patient with hepatic focal nodular hyperplasia. Am Surg 2006; 72: 555-559
74. Al-Mukhaizeem KA, Rosenberg A, Sherker AH. Nodular regenerative hyperplasia of the liver: an under-recognized cause of portal hypertension in hematological disorders. Am J Hematol 2004; 75: 225-230
75. Trenschel GM, Schubert A, Dries V, Benz-Bohm G. Nodular regenerative hyperplasia of the liver: case report of a 13-year-old girl and review of the literature. Pediatr Radiol 2000; 30: 64-68
76. Tanaka M, Wanless IR. Pathology of the liver in Budd-Chiari syndrome: portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules. Hepatology 1998; 27: 488-496
77. Perlemuter G, Bigorgne A, Cassard-Doulcier AM, Naveau S. Nonalcoholic fatty liver disease: from pathogenesis to patient care. Nat Clin Pract Endocrinol Metab 2007; 3: 458-469
78. Karcaaltincaba M, Akhan O. Imaging of hepatic steatosis and fatty sparing. Eur J Radiol 2007; 61: 33-43
79. Wheeler DA, Edmondson HA. Cystadenoma with mesenchymal stroma (CMS) in the liver and bile ducts. A clinicopathologic study of 17 cases, 4 with malignant change. Cancer 1985; 56: 1434-1445
80. Lam CM, Yuen ST, Yuen WK, Fan ST. Biliary papillomatosis. Br J Surg 1996; 83: 1715-1716
81. Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol 1995; 19: 859-872
82. Tamura S, Kihara Y, Yuki Y, Sugimura H, Shimizu T, Adjei ON, Watanabe K. Pseudo lesions on CTAP secondary to arterio-portal shunts. Clin Imaging 1997; 21: 359-365
83. Schwartz L, Brody L, Brown K, Covey A, Tuorto S, Mazumdar M, Riedel E, Jarnagin W, Getrajdman G, Fong Y. Prospective, blinded comparison of helical CT and CT arterial portography in the assessment of hepatic metastasis from colorectal carcinoma. World J Surg 2006; 30: 1892-1899; discussion 1900-1901
84. Leen E, Ceccotti P, Moug SJ, Glen P, MacQuarrie J, Angerson WJ, Albrecht T, Hohmann J, Oldenburg A, Ritz JP, Horgan PG. Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection? Ann Surg 2006; 243: 236-240
85. Nagaoka S, Itano S, Ishibashi M, Torimura T, Baba K, Akiyoshi J, Kurogi J, Matsugaki S, Inoue K, Tajiri N, Takada A, Ando E, Kuromatsu R, Kaida H, Kurogi M, Koga H, Kumashiro R, Hayabuchi N, Kojiro M, Sata M. Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findings. Liver Int 2006; 26: 781-788
86. Schillaci O. Somatostatin receptor imaging in patients with neuroendocrine tumors: not only SPECT? J Nucl Med 2007; 48: 498-500
87. Seemann MD, Meisetschlaeger G, Gaa J, Rummeny EJ. Assessment of the extent of metastases of gastrointestinal carcinoid tumors using whole-body PET, CT, MRI, PET/CT and PET/MRI. Eur J Med Res 2006; 11: 58-65
88. Wee A. Fine needle aspiration biopsy of the liver: Algorithmic approach and current issues in the diagnosis of hepatocellular carcinoma. Cytojournal 2005; 2: 7
89. Soreide O, Czerniak A, Bradpiece H, Bloom S, Blumgart L. Characteristics of fibrolamellar hepatocellular carcinoma. A study of nine cases and a review of the literature. Am J Surg 1986; 151: 518-523
90. Craig JR, Peters RL, Edmondson HA, Omata M. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer 1980; 46: 372-379
91. Brandt DJ, Johnson CD, Stephens DH, Weiland LH. Imaging of fibrolamellar hepatocellular carcinoma. AJR Am J Roentgenol 1988; 151: 295-299
92. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin 1998; 48: 6-29
93. Callea F, Sergi C, Fabbretti G, Brisigotti M, Cozzutto C, Medicina D. Precancerous lesions of the biliary tree. J Surg Oncol Suppl 1993; 3: 131-133
94. Watanapa P. Cholangiocarcinoma in patients with opisthorchiasis. Br J Surg 1996; 83: 1062-1064
95. Shin HR, Lee CU, Park HJ, Seol SY, Chung JM, Choi HC, Ahn YO, Shigemastu T. Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea. Int J Epidemiol 1996; 25: 933-940
96. Suzuki M, Takahashi T, Ouchi K, Matsuno S. The development and extension of hepatohilar bile duct carcinoma. A three-dimensional tumor mapping in the intrahepatic biliary tree visualized with the aid of a graphics computer system. Cancer 1989; 64: 658-666
97. Nichols JC, Gores GJ, LaRusso NF, Wiesner RH, Nagorney DM, Ritts RE Jr. Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc 1993; 68: 874-879
98. Nesbit GM, Johnson CD, James EM, MacCarty RL, Nagorney DM, Bender CE. Cholangiocarcinoma: diagnosis and evaluation of resectability by CT and sonography as procedures complementary to cholangiography. AJR Am J Roentgenol 1988; 151: 933-938
99. Tillich M, Mischinger HJ, Preisegger KH, Rabl H, Szolar DH. Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma. AJR Am J Roentgenol 1998; 171: 651-658
100. Dunk AA, Spiliadis H, Sherlock S, Fowler MJ, Monjardino JP, Scheuer PJ, Thomas HC. Hepatocellular carcinoma: clinical, aetiological and pathological features in British patients. Int J Cancer 1988; 41: 17-23
101. Dean PJ, Haggitt RC, O'Hara CJ. Malignant epithelioid hemangioendothelioma of the liver in young women. Relationship to oral contraceptive use. Am J Surg Pathol 1985; 9: 695-704
102. Ashraf S, Ashraf HM, Mamoon N, Luqman M. Epithelioid hemangioendothelioma of the liver. J Coll Physicians Surg Pak 2007; 17: 280-282
103. Bufton S, Haydon G, Neil D. Liver transplantation for hepatic epithelioid hemangioendothelioma: a case series. Prog Transplant 2007; 17: 70-72
104. Teoh AY, Ng SS, Lee KF, Lai PB. Biliary cystadenoma and other complicated cystic lesions of the liver: diagnostic and therapeutic challenges. World J Surg 2006; 30: 1560-1566
105. Hai S, Hirohashi K, Uenishi T, Yamamoto T, Shuto T, Tanaka H, Kubo S, Tanaka S, Kinoshita H. Surgical management of cystic hepatic neoplasms. J Gastroenterol 2003; 38: 759-764
106. Schmitt A, Gilden DJ, Saint S, Moseley RH. Clinical problem-solving. Empirically incorrect. N Engl J Med 2006; 354: 509-514
107. Zornoza J, Ginaldi S. Computed tomography in hepatic lymphoma. Radiology 1981; 138: 405-410
108. Belhadj K, Reyes F, Farcet JP, Tilly H, Bastard C, Angonin R, Deconinck E, Charlotte F, Leblond V, Labouyrie E, Lederlin P, Emile JF, Delmas-Marsalet B, Arnulf B, Zafrani ES, Gaulard P. Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 2003; 102: 4261-4269
109. Kuroda N, Mizobuchi M, Shimamura Y, Daibata M, Miyoshi I, Ohara M, Hirouchi T, Mizuno K, Lee GH. Bridging necrosis and reticulin bridging fibrosis induced by intrahepatic involvement of acute biphenotypic leukemia. APMIS 2006; 114: 908-911
110. Dellon ES, Morris SR, Tang W, Dunphy CH, Russo MW. Acute liver failure due to natural killer-like T-cell leukemia/lymphoma: a case report and review of the literature. World J Gastroenterol 2006; 12: 4089-4092
111. Powell N, Rusli F, Hubscher SG, Karanth M, Mutimer D. Adult T-cell leukemia presenting with acute liver failure. Leuk Res 2006; 30: 1315-1317
112. Ando K, Miyazawa K, Kuriyama Y, Kimura Y, Mukai K, Ohyashiki K. Hemophagocytic syndrome associated with CD8 positive T-cell chronic lymphocytic leukemia. Leuk Lymphoma 2004; 45: 193-198
113. Kraut EH. Clinical manifestations and infectious complications of hairy-cell leukaemia. Best Pract Res Clin Haematol 2003; 16: 33-40
114. Shah NA, Urusova IA, D'Agnolo A, Colquhoun SD, Rosenbloom BE, Vener SL, Geller SA, Younes M, Lechago J, Heaney AP. Primary hepatic carcinoid tumor presenting as Cushing's syndrome. J Endocrinol Invest 2007; 30: 327-333
115. Garrot C, Stuart K. Liver-directed therapies for metastatic neuroendocrine tumors. Hematol Oncol Clin North Am 2007; 21: 545-560; ix-x
116. Kulke M. Advances in the treatment of neuroendocrine tumors. Curr Treat Options Oncol 2005; 6: 397-409
117. Locker GY, Doroshow JH, Zwelling LA, Chabner BA. The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literature. Medicine (Baltimore) 1979; 58: 48-64
118. Lao XM, Chen DY, Zhang YQ, Xiang J, Guo RP, Lin XJ, Li JQ. Primary carcinosarcoma of the liver: clinicopathologic features of 5 cases and a review of the literature. Am J Surg Pathol 2007; 31: 817-826
119. Zampieri N, Camoglio F, Corroppolo M, Cecchetto M, Ornis S, Ottolenghi A. Botryoid rhabdomyosarcoma of the biliary tract in children: a unique case report. Eur J Cancer Care (Engl) 2006; 15: 463-466
120. Chan G, Horton PJ, Thyssen S, Lamarche M, Nahal A, Hill DJ, Marliss EB, Metrakos P. Malignant transformation of a solitary fibrous tumor of the liver and intractable hypoglycemia. J Hepatobiliary Pancreat Surg 2007; 14: 595-599
121. Saint-Paul MC, Gugenheim J, Hofman P, Arpurt JP, Fabiani P, Michiels JF, Fujita N, Goubeaux B, Loubière R, Delmont J. [Leiomyosarcoma of the liver: a case treated by transplantation] Gastroenterol Clin Biol 1993; 17: 218-222
122. Heiken JP. Liver. In: Lee JKT, Sagel SS, Stanley RJ, Heiken JP, eds. Computed Body Tomography with MRI Correlation. Philadelphia: Lippincott-Raven, 1998: 701-779
123. Harned RK 2nd, Chezmar JL, Nelson RC. Imaging of patients with potentially resectable hepatic neoplasms. AJR Am J Roentgenol 1992; 159: 1191-1194
124. Small WC, Mehard WB, Langmo LS, Dagher AP, Fishman EK, Heiken JP, Bernardino ME. Preoperative determination of the resectability of hepatic tumors: efficacy of CT during arterial portography. AJR Am J Roentgenol 1993; 161: 319-322
125. Heyneman LE, Nelson RC. Modality for imaging liver tumors. In: Clavien PA, ed. Malignant Liver Tumors: Current and Emerging Therapies. Malden: Blackwell Science, 1999: 46-62
126. Takamori R, Wong LL, Dang C, Wong L. Needle-tract implantation from hepatocellular cancer: is needle biopsy of the liver always necessary? Liver Transpl 2000; 6: 67-72
127. Francque SM, De Pauw FF, Van den Steen GH, Van Marck EA, Pelckmans PA, Michielsen PP. Biopsy of focal liver lesions: guidelines, comparison of techniques and cost-analysis. Acta Gastroenterol Belg 2003; 66: 160-165
128. Assy N, Pruzansky Y, Gaitini D, Shen Orr Z, Hochberg Z, Baruch Y. Growth hormone-stimulated IGF-1 generation in cirrhosis reflects hepatocellular dysfunction. J Hepatol 2008; 49: 34-42
129. Assy N, Hochberg Z, Amit T, Shen-Orr Z, Enat R, Baruch Y. Growth hormone-stimulated insulin-like growth factor (IGF) I and IGF-binding protein-3 in liver cirrhosis. J Hepatol 1997; 27: 796-802
130. Bouwman DL, Walt AJ. Current status of resection for hepatic neoplasms. Semin Liver Dis 1983; 3: 193-202
131. Frezza EE. Therapeutic management algorithm in cirrhotic and noncirrhotic patients in primary or secondary liver masses. Dig Dis Sci 2004; 49: 866-871